Vita Coco director sells 15,000 shares after exercise

Vita Coco Company, Inc. director Jane Cecil Morreau reported option exercises and a related share sale.

Rhea-AI Filing Summary

Vita Coco Company, Inc. director Jane Cecil Morreau reported option exercises and a related share sale. On February 23, 2026, she exercised non-qualified stock options in three steps, converting them into a total of 15,000 shares of common stock at $10.178 per share.

That same day she sold 15,000 shares of Vita Coco common stock at an average price of $53.91 per share in an open-market transaction executed under a Rule 10b5-1 trading plan. After these transactions, she directly owned 17,179 common shares of Vita Coco.

Insider Trade Summary

Exercise and Sale: 15,000 shares ($656K approx. pre-tax spread)

Exercise and Sale 7 txns

Insider Morreau Jane Cecil

Role Director

Sold 15,000 shs ($809K)

Approx. gross sale proceeds $809K

Approx. exercise cost $153K

Approx. pre-tax spread $656K

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (Right to Buy)	5,000	$0.00	$0.00
Exercise	Non-Qualified Stock Option (Right to Buy)	5,000	$0.00	$0.00
Exercise	Non-Qualified Stock Option (Right to Buy)	5,000	$0.00	$0.00
Exercise	Common Stock	5,000	$10.178	$51K
Exercise	Common Stock	5,000	$10.178	$51K
Exercise	Common Stock	5,000	$10.178	$51K
Sale	Common Stock	15,000	$53.91	$809K

Holdings After Transaction: Non-Qualified Stock Option (Right to Buy) — 30,500 contracts (Direct); Common Stock — 17,179 shares (Direct)

Footnotes (2)

1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. F2. The stock option is fully vested and currently exercisable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vita Coco (COCO) director Jane Cecil Morreau report?

Jane Cecil Morreau reported exercising stock options into 15,000 Vita Coco shares and selling 15,000 common shares. The transactions occurred on February 23, 2026 and were disclosed on a Form 4 insider ownership report.

How many Vita Coco (COCO) shares did the director sell and at what price?

She sold 15,000 shares of Vita Coco common stock at an average price of $53.91 per share. The transaction was classified as an open-market or private sale under transaction code “S.”

Were the Vita Coco (COCO) insider sales made under a 10b5-1 trading plan?

Yes, the filing states the sales of Vita Coco common stock were effected pursuant to a Rule 10b5-1 trading plan. Such plans pre-schedule trades, allowing insiders to systematically sell shares over time under predetermined conditions.

What option activity did the Vita Coco (COCO) director report on Form 4?

She reported exercising non-qualified stock options, classified with transaction code “M” for derivative exercise or conversion. These fully vested, currently exercisable options were converted into 15,000 shares of Vita Coco common stock on February 23, 2026.

How many Vita Coco (COCO) shares does the director hold after these transactions?

After completing the reported option exercises and share sale, the director directly owned 17,179 shares of Vita Coco common stock. This post-transaction balance reflects her remaining direct equity stake as shown in the Form 4 data.

Is the Vita Coco (COCO) director’s stock option already vested?

Yes, a footnote explains that the stock option is fully vested and currently exercisable. This means the director had the right to exercise the option immediately, enabling conversion into Vita Coco common shares before the reported sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 05:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morreau Jane Cecil

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		M		5,000	A	$10.178	22,179	D
Common Stock	02/23/2026		M		5,000	A	$10.178	27,179	D
Common Stock	02/23/2026		M		5,000	A	$10.178	32,179	D
Common Stock	02/23/2026		S(1)		15,000	D	$53.91	17,179	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$10.178	02/23/2026		M			5,000	(2)	07/12/2031	Common Stock	5,000	$0	40,500	D
Non-Qualified Stock Option (Right to Buy)	$10.178	02/23/2026		M			5,000	(2)	07/12/2031	Common Stock	5,000	$0	35,500	D
Non-Qualified Stock Option (Right to Buy)	$10.178	02/23/2026		M			5,000	(2)	07/12/2031	Common Stock	5,000	$0	30,500	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option is fully vested and currently exercisable.

	Alison Klein, Attorney-in-Fact For: Jane Morreau	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.